CRESCENT BIOPHARMA INC.

Q2 2025 13F Holders

Symbol
CBIO
CUSIP
G2545C104
Type
Equity
Class
COM
Num filings
32
Total reported value, excl. options
$174 M
Manager Report Date Value ($000) Shares Option Type